For access to the full note, please contact Naresh Chouhan ( ) With EU Pharma (ex-Novo) now having reached decade high valuations vs EuroStoxx600, we believe the sector has broken out & the sustainability of the growth profile will now generate continued strong performance. Consensus 5yr sales & EPS CAGR’s stand at 4% & 7% for 15x 2026 PE. We show there is upside to this from underestimated pipelines where cons. rarely fully models “monster” drugs & from M&A which we expect to be strong at JPM ...
Novartis breaks ground on flagship manufacturing hub in North Carolina FDA Commissioner Marty Makary, North Carolina Governor Josh Stein and Novartis leadership highlight importance of new hub to US patients and local economyConstruction reflects company’s commitment to ensure end-to-end manufacturing of all key medicines for US patients in the US at scaleGroundbreaking marks continuation of Novartis investment and growth in the US, capping year of significant regulatory and manufacturing milestones East Hanover, December 12, 2025 – Novartis, a leading global innovative medicines company...
Ageas to take full ownership of AG Insurance and formalise long term partnership with BNP Paribas Ageas to take full ownership of AG Insurance and formalise long term partnership with BNP Paribas Ageas SA/NV (“Ageas”, the “Group”) today announced the acquisition of the outstanding 25% stake in its Belgian subsidiary AG Insurance SA/NV (“AG”) from BNP Paribas Fortis SA/NV (“BNP Paribas Fortis”). This transaction further accelerates and upgrades Ageas’s Elevate27 strategic and financial ambitions for the second time this year. Additionally, Ageas and BNP Paribas SA (“BNP Paribas”) reconfirm...
Ageas prend la pleine propriété d’AG Insurance et formalise un partenariat à long terme avec BNP Paribas Ageas prend la pleine propriété d’AG Insurance et formalise un partenariat à long terme avec BNP Paribas Ageas SA/NV (« Ageas », le « Groupe ») annonce aujourd’hui l’acquisition de la participation de 25 % du capital en circulation dans sa filiale belge AG Insurance SA/NV (« AG ») auprès de BNP Paribas Fortis SA/NV (« BNP Paribas Fortis »). Cette transaction accélère et renforce les ambitions stratégiques et financières d’Ageas dans le cadre du plan Elevate27, pour la deuxième fois cett...
Ageas wordt 100% eigenaar van AG en formaliseert lange-termijnpartnerschap met BNP Paribas Ageas wordt 100% eigenaar van AG en formaliseert lange-termijnpartnerschap met BNP Paribas Ageas SA/NV (“Ageas”, de “Groep”) kondigt vandaag de overname aan van het uitstaande belang van 25% in haar Belgische dochteronderneming AG Insurance SA/NV (“AG”) van BNP Paribas Fortis SA/NV (“BNP Paribas Fortis”). Met deze transactie versnelt en versterkt Ageas zijn strategische en financiële ambities binnen Elevate27 voor de tweede keer dit jaar. Daarnaast herbevestigen Ageas en BNP Paribas SA (“BNP Paribas”...
Aalberts updated the market on its divestment programme as announced at last December's CMD. We appreciate the execution of the strategic plan which so far resulted in the July acquisition of the South-Asian semicon player GVT and today's disposals of some European Industrial and Building operations. As the disposal of Metalis (Industry) and equity dilution in KAN (Building) will only result in a modest book profit we estimate the transaction will not trigger a large SBB, especially as the dilut...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.